DiaSorin S.p.A. (BIT:DIA)
58.26
-0.96 (-1.62%)
At close: Mar 27, 2026
DiaSorin Revenue
DiaSorin had revenue of 280.00M EUR in the quarter ending September 30, 2025, a decrease of -2.44%. This brings the company's revenue in the last twelve months to 1.21B, up 2.56% year-over-year. In the year 2024, DiaSorin had annual revenue of 1.19B with 3.24% growth.
Revenue (ttm)
1.21B
Revenue Growth
+2.56%
P/S Ratio
2.63
Revenue / Employee
368.60K
Employees
3,280
Market Cap
3.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 37.22M | 3.24% |
| Dec 31, 2023 | 1.15B | -212.93M | -15.64% |
| Dec 31, 2022 | 1.36B | 123.48M | 9.98% |
| Dec 31, 2021 | 1.24B | 356.35M | 40.43% |
| Dec 31, 2020 | 881.31M | 174.99M | 24.77% |
| Dec 31, 2019 | 706.32M | 37.12M | 5.55% |
| Dec 31, 2018 | 669.20M | 31.71M | 4.97% |
| Dec 31, 2017 | 637.49M | 68.18M | 11.97% |
| Dec 31, 2016 | 569.31M | 70.13M | 14.05% |
| Dec 31, 2015 | 499.18M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| Safilo Group | 983.38M |
| EL.En. | 590.85M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 487.08M |
| Svas Biosana | 134.95M |
| Pharmanutra | 133.97M |
DiaSorin News
- 7 days ago - Diasorin SpA (DSRLF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Global ... - GuruFocus
- 7 days ago - Full Year 2025 DiaSorin SpA Earnings Call Transcript - GuruFocus
- 1 year ago - Italy's DiaSorin ex-Covid revenue in line with guidance - Reuters
- 1 year ago - Diagnostics group DiaSorin's nine-month adjusted core profit up 6% - Reuters
- 2 years ago - Diasorin 2023 revenue drops 14%, in line with guidance; shares fall - Reuters
- 4 years ago - Italy's DiaSorin sees 60% plunge in COVID-19 revenue next year - Reuters
- 4 years ago - The Vanguard Health Care Fund's Top 5 Trades of the 3rd Quarter - GuruFocus
- 5 years ago - Luminex Corporation Declares Second Quarter Cash Dividend - PRNewsWire